Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-05-07

Synthesis of divergent intermediates for the generation of analogues of spicamycin for the study and treatment of cancer and tuberculosis

Ziel



Research objectives and content
The synthesis of divergent intermediates for the generation of spicamycin and analogues, which may be promising as potential cancer and tuberculosis therapeutics.
Training content (objective, benefit and expected impact)
This project provides an opportunity to do exciting chemistry, using new techniques and aspects of modern synthetic and bioorganic chemistry. Links with industry / industrial relevance (22)
The project will receive an important support from pharmaceutical c companies. We will work in collaboration with their biologists.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Daten nicht verfügbar

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
EU-Beitrag
Keine Daten
Adresse
South Parks Road
OX1 3QY OXFORD
Vereinigtes Königreich
Gesamtkosten
Keine Daten

Beteiligte (1)